Suppr超能文献

乙型和丙型肝炎病毒标志物评估:对美国亚裔和白种人肝细胞癌患者的临床意义

Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America.

作者信息

Hwang S J, Tong M J, Lai P P, Ko E S, Co R L, Chien D, Kuo G

机构信息

Liver Centre, Huntington Memorial Hospital, Pasadena, California 91105, USA.

出版信息

J Gastroenterol Hepatol. 1996 Oct;11(10):949-54.

PMID:8912133
Abstract

In order to evaluate the roles of hepatitis B virus (HBV) and hepatitis C virus (HCV) and their clinical significance in Asian-American and Caucasian patients with hepatocellular carcinoma (HCC) in the USA, 110 HCC patients, seen in a community-based teaching hospital in the Los Angeles area over a 10 year period, were enrolled. Seventy-nine (72%) patients were Asian-American and 31 (28%) were Caucasians. Of the 110 HCC patients, 69 (63%) were positive for serum hepatitis B surface antigen (HBsAg), 26 (24%) were positive for serum antibody to hepatitis C virus (anti-HCV), five (all Asian-Americans) were positive for both markers; 11 (10%) patients had a history of alcoholism. HBsAg was detected in 63 (80%) Asian-American patients, significantly higher than in the six (19%) Caucasian HCC patients (P < 0.01). Anti-HCV was detected in 10 (32%) Caucasian and in 16 (20%) Asian-American HCC patients (P > 0.05). Among Asian-American HCC patients, anti-HCV was more prevalent in those who were HBsAg-negative than in the HBsAg-positive patients (69 vs 8%; P < 0.01). A history of alcoholism was obtained in nine (29%) Caucasian HCC patients, significantly higher than in the two (3%) Asian-American HCC patients (P < 0.05). Comparing HCC patients with positive HBsAg and with anti-HCV, HBsAg-positive HCC patients were younger, Asian-Americans and predominantly male; 38% had a family history of liver disease. In contrast, anti-HCV-positive HCC patients were older by nearly a decade and 46% had a history of blood transfusion. Using a stepwise logistic regression analysis, Asian race and patient age < 50 years were found to be independent predictors for HBsAg-positivity, while a history of blood transfusion was the only predictor for anti-HCV-positivity in HCC patients. There was no significant difference in the rate of cirrhosis, serum levels of alpha-fetoprotein and survival between HBsAg-positive and anti-HCV-positive HCC patients. In conclusion, chronic HBV infection was the major aetiological factor in Asian-American HCC patients, while chronic HCV infection and alcoholism were major aetiological factors in Caucasian HCC patients in the USA.

摘要

为了评估乙肝病毒(HBV)和丙肝病毒(HCV)在美国亚裔美国人和白种人肝细胞癌(HCC)患者中的作用及其临床意义,我们纳入了在洛杉矶地区一家社区教学医院10年间收治的110例HCC患者。其中79例(72%)为亚裔美国人,31例(28%)为白种人。在这110例HCC患者中,69例(63%)血清乙肝表面抗原(HBsAg)呈阳性,26例(24%)血清丙肝病毒抗体(抗-HCV)呈阳性,5例(均为亚裔美国人)两种标志物均呈阳性;11例(10%)患者有酗酒史。63例(80%)亚裔美国患者检测到HBsAg,显著高于6例(19%)白种人HCC患者(P<0.01)。10例(32%)白种人和16例(20%)亚裔美国HCC患者检测到抗-HCV(P>0.05)。在亚裔美国HCC患者中,抗-HCV在HBsAg阴性患者中比在HBsAg阳性患者中更普遍(69%对8%;P<0.01)。9例(29%)白种人HCC患者有酗酒史,显著高于2例(3%)亚裔美国HCC患者(P<0.05)。比较HBsAg阳性和抗-HCV阳性的HCC患者,HBsAg阳性的HCC患者更年轻,为亚裔美国人且主要为男性;38%有肝病家族史。相比之下,抗-HCV阳性的HCC患者年龄大近十岁,46%有输血史。通过逐步逻辑回归分析发现,亚洲种族和患者年龄<50岁是HBsAg阳性的独立预测因素,而输血史是HCC患者抗-HCV阳性的唯一预测因素。HBsAg阳性和抗-HCV阳性的HCC患者在肝硬化发生率、甲胎蛋白血清水平和生存率方面无显著差异。总之,慢性HBV感染是亚裔美国HCC患者的主要病因,而慢性HCV感染和酗酒是美国白种人HCC患者的主要病因。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验